Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

AC Immune (ACIU) EPS (Weighted Average and Diluted) (2016 - 2022)

AC Immune has reported EPS (Weighted Average and Diluted) over the past 5 years, most recently at $1942.6 for Q1 2022.

  • Quarterly EPS (Weighted Average and Diluted) fell 86.82% to $1942.6 in Q1 2022 from the year-ago period, while the trailing twelve-month figure was $19796.7 through Sep 2019, changed N/A year-over-year, with the annual reading at -$0.88 for FY2025, 50.44% down from the prior year.
  • EPS (Weighted Average and Diluted) was $1942.6 for Q1 2022 at AC Immune, down from $14742.7 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $19796.7 in Q3 2019 and troughed at -$25222.4 in Q2 2019.
  • The 3-year median for EPS (Weighted Average and Diluted) is $8342.6 (2021), against an average of $2814.9.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 86.82% in 2022 against a maximum downside of 86.82% in 2022.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at $19796.7 in 2019, then dropped by 25.53% to $14742.7 in 2021, then plummeted by 86.82% to $1942.6 in 2022.
  • Per Business Quant, the three most recent readings for ACIU's EPS (Weighted Average and Diluted) are $1942.6 (Q1 2022), $14742.7 (Q1 2021), and $19796.7 (Q3 2019).